In a comment in the Lancet infectious Diseases, the Director of the Antibiotic Action initiative and an advisor to the Review said that “the ability of the Review to interact with, and influence the World Health Assembly, the G20, and the United Nations to act on their recommendations cannot be underestimated. If all the recommendations are fully implemented and antimicrobial resistance is overcome, this will be one of the most significant achievements of the 21st century, will save countless weeks and months of lost productivity, and will avert unnecessary deaths due to difficult and untreatable infections.”
The Institute and Faculty of Actuaries has published a longevity bulletin which examines the clinical implications, impacts on longevity and the potential economic cost of current trends in antimicrobial resistance (AMR).
NICE published a guideline on antimicrobial stewardship in 2015 which covers the effective use of antimicrobials. It aims to change prescribing practice to help slow the emergence of AMR and ensure that antimicrobials remain an effective treatment for infection.